Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Scalable Recombinant Adeno-Associated Virus Production Using Recombinant Herpes Simplex Virus Type 1 Coinfection of Suspension-Adapted Mammalian Cells

6 May 2009

Abstract excerpt

Recombinant adeno-associated virus (rAAV) production systems capable of meeting clinical or anticipated commercial-scale manufacturing needs have received relatively little scrutiny compared with the intense research activity afforded the in vivo and in vitro evaluation of rAAV for gene transfer. Previously we have reported a highly efficient recombinant herpes simplex virus type 1 (rHSV) complementation system...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19419276
DOI: 10.1089/hum.2009.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Scalable Recombinant Adeno-Associated Virus Production Using Recombinant Herpes Simplex Virus Type 1 Coinfection of Suspension-Adapted Mammalian CellsPMID 19419276Read ↗

Engineered CHO cells as a novel AAV production platform for gene therapy deliverySemantic proximity Read ↗

Recombinant adeno‐associated virus production evaluation in Chinese hamster ovary cellsSemantic proximity Read ↗

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapSemantic proximity Read ↗

Production of Recombinant Adeno-Associated Virus VectorsSemantic proximity Read ↗

Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy ManufacturingSemantic proximity Read ↗

Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.Semantic proximity Read ↗

Scalable production of adeno‐associated virus type 2 vectors via suspension transfectionSemantic proximity Read ↗

Towards a scalable bioprocess for rAAV production using a HeLa stable cell lineSemantic proximity Read ↗

Molecular design for recombinant adeno-associated virus (rAAV) vector productionSemantic proximity Read ↗

Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical StudiesSemantic proximity Read ↗

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral VectorsSemantic proximity Read ↗

Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at ScaleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.